Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728194 | SCV000855738 | uncertain significance | not provided | 2017-07-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485855 | SCV002790565 | uncertain significance | Alpha-1-antitrypsin deficiency | 2022-02-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002485855 | SCV003280150 | likely benign | Alpha-1-antitrypsin deficiency | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003918187 | SCV004730174 | likely benign | SERPINA1-related disorder | 2023-08-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |